Pharmaceuticals in Scandinavia
Summary
Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Scandinavian pharmaceuticals market registered revenues of $17.4 billion in 2023, representing a compound annual growth rate (CAGR) of 3.4% between 2018 and 2023
- Sweden dominated the Scandinavian pharmaceuticals market in 2023, accounting for the largest share of 38.1% in 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts
- What was the size of the Scandinavia pharmaceuticals market by value in 2023?
- What will be the size of the Scandinavia pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Scandinavia's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. F. Hoffmann-La Roche Ltd
- 8.2. Novo Nordisk AS
- 8.3. H. Lundbeck AS
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Scandinavia pharmaceuticals market value: $ billion, 2018-23
- Table 2: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: F. Hoffmann-La Roche Ltd: key facts
- Table 5: F. Hoffmann-La Roche Ltd: Key Employees
- Table 6: Novo Nordisk AS: key facts
- Table 7: Novo Nordisk AS: Annual Financial Ratios
- Table 8: Novo Nordisk AS: Key Employees
- Table 9: H. Lundbeck AS: key facts
- Table 10: H. Lundbeck AS: Annual Financial Ratios
- Table 11: H. Lundbeck AS: Key Employees
- Table 12: Scandinavia exchange rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook